ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 7,690.00
-480.00 (-5.88%)
Jun 30, 2026, 3:30 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 84.82 billion as of June 30, 2026. Its market cap has decreased by -38.89% in one year.
Market Cap
84.82B
Enterprise Value
63.03B
Revenue
4.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,690.00
Market Cap Chart
Since August 23, 2024, ENCell's market cap has decreased from 160.82B to 84.82B, a decrease of -47.26%. That is a compound annual growth rate of -29.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 84.82B | -57.27% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 126.74B |
| NeoImmuneTech | 124.57B |
| Genexine | 104.60B |
| Amicogen | 103.28B |
| MedPacto | 96.31B |
| Vaxcell-Bio Therapeutics | 92.10B |
| CG Invites | 78.28B |
| iNtRON Biotechnology | 74.77B |